May 16, 2020

Caring for dry eye patients through the coronavirus pandemic Cynthia Matossian, MD, FACS, shares how her practice has continued to offer patient services via telemedicine appointments, common compliance issues she’s come across, and how to provide virtual care. Read more ADVERTISEMENT   Determining risk of ocular damage from chronic intravitreal injections Because these injections have been used for a relatively short period, the definitive consequences of chronic use remain to be determined. Learn more ADVERTISEMENT

Innovations from enucleation: Where can we go from here? Ocular enucleation is inevitable for some patients; but for others, new therapies might spare the eye. If it must happen, there are ways to ease that road for patients. Find out ADVERTISEMENT

RELATED ARTICLES

Blockchain technology aims to drive big data to ‘train’ AI The dropless future: SLT as a first-line treatment for glaucoma Pharmacologic treatment an option for open-angle glaucoma Genetics analysis may predict myopia in children Putting technologies into practice not perfect science Diagnosing LSCD noninvasively: SD-OCT preferred technology Researchers eye cure, diagnostics for adenoviral conjunctivitis Fluorescein angiography key in diagnosing retinal diseases